Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today executed a licensing agreement with Kwangdong Pharmaceutical, ...

Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced an agreement to collaborate with ...

CPT codes for OGM are key components for obtaining reimbursement from third party payers when labs use LDTs based on OGM as alternatives to legacy cytogenetics methods such as karyotyping, ...

Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that the Company’s Board of Directors approved, and the ...

Esophageal varices are a common and severe complication of advanced liver disease, associated with a high risk of life-threatening gastrointestinal bleeding. Their resolution in a patient with ...

FRISCO, Texas, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the promotion of Holly Flax to the ...

Harrow’s Investor & Analyst Day will include a comprehensive overview of Harrow’s business, featuring presentations from the Company’s leadership team covering the full scope of Harrow’s commercial ...

Publication described treatment of patients with Symvess who had hospital-acquired iatrogenic injuries or complications of vascular surgical procedures - - Patients treated with Symvess were observed ...

Glendale, CA, Sept. 15, 2025 (GLOBE NEWSWIRE) -- In an exciting turn of events, Happy Go Leafy announced that its newly-released Red Bali Kratom products (powder and capsules) had sold out in a few ...

Plastic Surgery Key, an independent research organization, released its annual assessment of the best kratom brands 2025, and ranked Happy Go Leafy at the #1 position in the online purchase category.

CE Mark for RECELL ® GO is an important milestone for AVITA Medical and for patients,” said Jim Corbett, Chief Executive Officer of AVITA Medical. “It enables us to bring this option to burn centers ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the successful commercial launch of Ryoncil ® (remestemcel-L-rknd), ...